The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study aims to investigate the value of 18F-FDG and 68Ga-FAPI PET/CT in evaluating the outcome of conversion therapy and the prognosis of advanced colorectal cancer (peritoneal metastasis with/without other metastases)
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Histologically confirmed colorectal cancer, clinical or other imaging suspicion of peritoneal metastasis with or without other distant metastases.
• Patients voluntarily enrolled in this study by signing an informed consent form
• Age ≥ 18 years
• Expected life expectancy ≥ 3 months
• Adequate organ and bone marrow function
• Willingness to adhere to the study protocol and follow-up programme
Locations
Other Locations
China
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
RECRUITING
Shanghai
Contact Information
Primary
Jiajia Hu
jiajiahu@shsmu.edu.cn
13524945287
Time Frame
Start Date: 2025-02-01
Estimated Completion Date: 2029-03-31
Participants
Target number of participants: 30
Treatments
Patients diagnosis of advanced colorectal cancer
Patients diagnosis of advanced colorectal cancer (peritoneal metastasis with/without other metastases)
Related Therapeutic Areas
Sponsors
Leads: Ruijin Hospital